Annual Meeting of the French Reference Center for Superficial Vascular Anomalies

Paris’s leading center for rare vascular anomalies has convened its third annual meeting, marking a key milestone in the coordinated care and research of superficial vascular malformations in France. The event, held on June 18, 2026, brought together clinicians, researchers, and patient advocates under the auspices of the National Coordinating Reference Center for Rare Superficial Vascular Anomalies (CRMR), a network accredited by the French Ministry of Health.

Focus on Care Coordination and Research

The meeting, hosted by the multi-disciplinary team from Lariboisière, Bichat, and Necker hospitals, emphasized two core objectives: improving care coordination across France and advancing research into these rare conditions. According to the center’s official materials, the event served as a platform to discuss diagnostic protocols, treatment innovations, and patient support strategies for superficial vascular anomalies, which include conditions such as capillary malformations, lymphatic malformations, and arteriovenous malformations.

The CRMR operates within the broader FAVA-Multi network, a healthcare framework dedicated to rare vascular diseases with multi-system involvement. This structure connects 2 national reference centers and 12 centers of expertise across France, ensuring standardized care and equitable access for patients regardless of location. The 2026 meeting underscored the network’s role in harmonizing clinical practices and fostering collaboration between specialists in dermatology, radiology, genetics, and surgery.

Patient-Centered Initiatives

A highlight of the event was the inclusion of patient perspectives, particularly through a dedicated support group session held on April 15, 2026. Titled “Groupe de parole : Être parent d’un enfant AVS” (Support Group: Being a Parent of a Child with Superficial Vascular Anomalies), the virtual session provided a forum for families to share experiences and challenges. Such initiatives reflect the center’s commitment to integrating patient voices into care pathways, a priority outlined in its mission to improve quality of life for individuals living with these conditions.

The CRMR’s patient-centered approach extends to educational resources, including detailed pathology fact sheets available on its website. These materials cover topics such as infantile hemangiomas, lymphatic malformations, and imaging techniques like embolization, offering accessible information for both patients and healthcare providers. The center’s FAQ section further addresses common concerns, from diagnostic processes to treatment options, reinforcing its role as a hub for reliable medical guidance.

Advancing Research and International Collaboration

Research remains a cornerstone of the CRMR’s work, with the 2026 meeting featuring updates on ongoing studies and collaborative projects. One notable event preceding the annual meeting was the PTEN Research Collaborators’ Meeting, held on March 11, 2026. While the CRMR’s primary focus is on superficial vascular anomalies, its participation in broader rare disease networks—such as the European Reference Network VASCERN—facilitates cross-disciplinary research into genetic and systemic aspects of vascular disorders.

Dr. Annouk-Anne Bisdorff-Bresson, coordinator of the CRMR and a board member of the International Society for the Study of Vascular Anomalies (ISSVA), has been instrumental in shaping the center’s research agenda. Her leadership underscores the intersection of clinical care and scientific inquiry, particularly in rare conditions where diagnostic and therapeutic gaps persist. The CRMR’s collaboration with international bodies like ISSVA ensures alignment with global best practices, as seen in its contributions to diagnostic pathways and clinical guidelines.

Diagnostic and Therapeutic Challenges

Superficial vascular anomalies present complex diagnostic challenges due to their rarity and diverse clinical presentations. The CRMR’s work addresses these challenges through standardized imaging protocols and multidisciplinary consultations. For example, the center’s Lariboisière site specializes in arteriovenous malformations, offering specialized diagnostic and therapeutic pathways for both adult and pediatric patients. This targeted approach aims to reduce misdiagnosis and ensure timely intervention, particularly for conditions that may progress without appropriate management.

Treatment strategies discussed at the 2026 meeting included advances in embolization techniques and sclerotherapy for vascular malformations. While these interventions can alleviate symptoms and improve cosmetic outcomes, the CRMR emphasizes the need for long-term follow-up and personalized care plans. The center’s research efforts also explore the genetic underpinnings of these conditions, with the goal of identifying biomarkers and targeted therapies.

Looking Ahead: Policy and Advocacy

The CRMR’s accreditation as a national reference center reflects France’s broader commitment to addressing rare diseases through coordinated care networks. By 2026, the center has expanded its reach, relabeling and accrediting additional centers of expertise to strengthen the national infrastructure. This expansion aligns with the French Ministry of Health’s strategy to improve equity in healthcare access, particularly for patients in underserved regions.

Patient advocacy remains a critical component of the CRMR’s mission. The center collaborates closely with patient associations to amplify voices within the rare disease community, ensuring that policy decisions and research priorities reflect the needs of those directly affected. Initiatives like the April 2026 support group session exemplify this partnership, fostering a sense of community and shared purpose among families navigating these conditions.

Conclusion

The third annual meeting of the National Coordinating Reference Center for Rare Superficial Vascular Anomalies highlights the progress and ongoing challenges in managing these complex conditions. By prioritizing care coordination, research, and patient engagement, the CRMR serves as a model for rare disease networks both in France and internationally. As the center continues to expand its collaborations and refine its clinical pathways, its work offers hope for improved outcomes and greater awareness of superficial vascular anomalies.

For patients and families seeking more information, the CRMR’s website provides a wealth of resources, including pathology fact sheets, FAQs, and contact details for specialized consultations. The center’s commitment to transparency and education underscores its role as a trusted source of support and expertise in the field of rare vascular diseases.